# Intranasal Versus Intravenous Drug in Painful Procedure for Outpatient Oncologic Participants

> **NCT04621110** · PHASE3 · UNKNOWN · sponsor: **University of Sao Paulo General Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Pediatric Cancer
- Analgesia
- Procedural Pain

## Interventions

- **DRUG:** intranasal dexmedetomidine
- **DRUG:** intranasal fentanyl
- **DRUG:** intravenous ketamine (ketalar®)
- **DRUG:** intravenous midazolam

## Key facts

- **NCT ID:** NCT04621110
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-01
- **Primary completion:** 2021-09
- **Final completion:** 2021-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04621110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04621110, "Intranasal Versus Intravenous Drug in Painful Procedure for Outpatient Oncologic Participants". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04621110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*